ESR1 and neoplasm: For example, RUNX3 is considered to act as a new tumor suppressor gene in the breast for degradation by targeting the estrogen receptor [32], and different post-translational modifications affect the tumor suppressor function of RUNX3, such as stability, subcellular localization, and transactivation activity [33].